A new material developed at Cornell could significantly improve the delivery and effectiveness of mRNA vaccines – used to fight COVID-19 – by replacing a commonly used ingredient that may trigger unwanted immune responses in some people.
The new platform, which provided 100% protection from influenza and COVID-19 in mouse models, could vastly improve vaccine administration and the efficacy of the current flu vaccine.
Cornell researchers are helping upgrade the CMS detector at CERN, as LHC collaborations win the 2024 Breakthrough Prize for fundamental physics discoveries.
More than five years after a landmark study in the journal Science showed that North American bird populations declined by nearly 30% since 1970, a new report finds that the concerning trend is continuing apace.
Using data from two of New York's largest grape–producing regions, researchers found that losses could reach $1.5 million, $4 million and $8.8 million in the first, second and third years of infestation, respectively.
The project - which has expanded to four SUNY schools and to younger kids nationally - has disbursed more than $500,000 to over 1,300 participants, bolstering young people's sense of agency, community and purpose.
From a nanotech solution for removing toxic chemicals from water to a 3D-printing method for high-precision drug delivery, Cornell students put research innovations to the test in the first Technology Commercialization Innovation Competition.
ILR junior Jonathan Lam was recently named the inaugural recipient of the Trailblazer in Organizing and Activism Award given by Amnesty International USA. Lam and others were honored at the People Power Awards ceremony during the organization’s Annual General Meeting, held in February at the Westin Book Cadillac in Detroit.